232 related articles for article (PubMed ID: 26632890)
1. Second Hepatectomy Improves Survival in Patients With Microvascular Invasive Hepatocellular Carcinoma Meeting the Milan Criteria.
Hou YF; Li B; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LV; Chen KF
Medicine (Baltimore); 2015 Dec; 94(48):e2070. PubMed ID: 26632890
[TBL] [Abstract][Full Text] [Related]
2. Microvascular invasion patterns affect survival in hepatocellular carcinoma patients after second hepatectomy.
Hou YF; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LN; Li B; Chen KF
J Surg Res; 2016 Jan; 200(1):82-90. PubMed ID: 26259778
[TBL] [Abstract][Full Text] [Related]
3. Microvascular infiltration has limited clinical value for treatment and prognosis in hepatocellular carcinoma.
Portolani N; Baiocchi GL; Molfino S; Benetti A; Gheza F; Giulini SM
World J Surg; 2014 Jul; 38(7):1769-76. PubMed ID: 24378549
[TBL] [Abstract][Full Text] [Related]
4. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.
Imura S; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Saito Y; Iwahashi S; Ikemoto T; Morine Y; Shimada M
Int J Clin Oncol; 2018 Feb; 23(1):98-103. PubMed ID: 28875240
[TBL] [Abstract][Full Text] [Related]
5. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
[TBL] [Abstract][Full Text] [Related]
6. The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.
Han J; Li ZL; Xing H; Wu H; Zhu P; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Wu MC; Shen F; Yang T
HPB (Oxford); 2019 Aug; 21(8):962-971. PubMed ID: 30718183
[TBL] [Abstract][Full Text] [Related]
7. Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
Lei Z; Li J; Wu D; Xia Y; Wang Q; Si A; Wang K; Wan X; Lau WY; Wu M; Shen F
JAMA Surg; 2016 Apr; 151(4):356-63. PubMed ID: 26579636
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
[TBL] [Abstract][Full Text] [Related]
10. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.
Zhao H; Chen C; Fu X; Yan X; Jia W; Mao L; Jin H; Qiu Y
Oncotarget; 2017 Jan; 8(3):5474-5486. PubMed ID: 27729623
[TBL] [Abstract][Full Text] [Related]
12. Infiltrative Hepatocellular Carcinoma: Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy.
Yan X; Fu X; Deng M; Chen J; He J; Shi J; Qiu Y
Medicine (Baltimore); 2016 May; 95(19):e3589. PubMed ID: 27175659
[TBL] [Abstract][Full Text] [Related]
13. Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis.
Chen ZH; Zhang XP; Wang H; Chai ZT; Sun JX; Guo WX; Shi J; Cheng SQ
HPB (Oxford); 2019 Aug; 21(8):935-944. PubMed ID: 30871805
[TBL] [Abstract][Full Text] [Related]
14. [Association of microvascular invasion with recurrence and prognosis of patients with small hepatocellular carcinoma undergoing liver transplantation].
Zhu YB; Xu X; Zheng SS
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 43(6):658-63. PubMed ID: 25644564
[TBL] [Abstract][Full Text] [Related]
15. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma.
Du M; Chen L; Zhao J; Tian F; Zeng H; Tan Y; Sun H; Zhou J; Ji Y
BMC Cancer; 2014 Jan; 14():38. PubMed ID: 24460749
[TBL] [Abstract][Full Text] [Related]
16. Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
Cha DI; Kang TW; Jeong WK; Kim JM; Choi GS; Joh JW; Yi NJ; Ahn SH
Eur Radiol; 2024 Jan; 34(1):498-508. PubMed ID: 37505248
[TBL] [Abstract][Full Text] [Related]
17. Nomogram to Assist in Surgical Plan for Hepatocellular Carcinoma: a Prediction Model for Microvascular Invasion.
Lin S; Ye F; Rong W; Song Y; Wu F; Liu Y; Zheng Y; Siqin T; Zhang K; Wang L; Wu J
J Gastrointest Surg; 2019 Dec; 23(12):2372-2382. PubMed ID: 30820799
[TBL] [Abstract][Full Text] [Related]
18. Impact of Histological Factors of Hepatocellular Carcinoma on the Outcome of Liver Transplantation.
Donat M; Alonso S; Pereira F; Ferrero E; Carrión L; Acin-Gándara D; Moreno E
Transplant Proc; 2016; 48(6):1968-77. PubMed ID: 27569930
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
20. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.
Wang L; Wang W; Rong W; Li Z; Wu F; Liu Y; Zheng Y; Zhang K; Siqin T; Liu M; Chen B; Wu J
BMC Cancer; 2020 Jul; 20(1):614. PubMed ID: 32611327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
